By Nelson Vergel | ExcelMale.com | Updated December 2025
Introduction
Should you take an aromatase inhibitor with testosterone replacement therapy? This question has sparked considerable debate in men's health circles, with some clinics routinely prescribing anastrozole alongside TRT while others strongly advise against it. The truth lies in understanding the nuanced role estrogen plays in male physiology and when—if ever—blocking its production makes clinical sense.Anastrozole, marketed as Arimidex, is an aromatase inhibitor originally developed for treating hormone-sensitive breast cancer in postmenopausal women. Its off-label use in men on testosterone therapy has become widespread, yet remains controversial. While some practitioners view it as essential for managing elevated estrogen levels, accumulating evidence suggests that indiscriminate use may cause more harm than benefit.
This comprehensive guide examines the science behind anastrozole use in men, exploring when it might be appropriate, what risks it carries, and why many hormone specialists now recommend against routine co-administration with TRT. You'll learn about estrogen's critical functions in male health, the specific situations where anastrozole may be warranted, proper dosing protocols, and the important safety considerations every man should understand before starting this medication.
What is Anastrozole and How Does It Work?
Anastrozole belongs to a class of medications called third-generation aromatase inhibitors. These drugs work by blocking the aromatase enzyme, which converts testosterone into estradiol—the primary and most potent form of estrogen in the body. By inhibiting this conversion process, anastrozole effectively reduces circulating estrogen levels while allowing testosterone levels to remain elevated or potentially increase further.The aromatase enzyme is found throughout the body, with particularly high activity in adipose (fat) tissue, the liver, muscles, brain, and in men, the testes. When men receive exogenous testosterone through TRT, more substrate becomes available for aromatization. This is why testosterone therapy can lead to increases in both testosterone and estradiol levels—a natural physiological response that isn't necessarily problematic.
Third-generation aromatase inhibitors like anastrozole are highly potent and selective, meaning they don't significantly interfere with other steroidogenic enzymes. In postmenopausal women, these medications can suppress estrogen production by over 95%. However, in men, the effect is less dramatic due to higher baseline testosterone levels and continued testicular production. Studies show that anastrozole typically reduces the estradiol-to-testosterone ratio by approximately 77% in men, rather than eliminating estrogen completely.
The drug is taken orally, typically as a 1 mg tablet, though doses for men are often lower. It has a relatively long half-life of approximately 50 hours, which allows for less frequent dosing compared to some alternatives. Peak blood levels occur within 2 hours of administration, but clinical effects on hormone levels may take several days to fully manifest.
FDA Status and Off-Label Use
Anastrozole is FDA-approved specifically for the treatment of hormone receptor-positive breast cancer in postmenopausal women. Its use in men for any indication—including management of elevated estrogen during testosterone therapy—is considered off-label. This means that while physicians can legally prescribe it for male patients, the manufacturer's FDA-approved labeling does not include dosing recommendations, safety data, or efficacy information specific to men.The Endocrine Society's Clinical Practice Guidelines for Testosterone Therapy in Adult Men do not address the issue of elevated estradiol during TRT, nor do they recommend for or against treatments that lower estrogen levels. This absence of clinical guidance reflects the limited high-quality evidence supporting anastrozole use in men and the ongoing uncertainty about when intervention is truly necessary.
The Critical Role of Estrogen in Men
Understanding why blocking estrogen can be problematic requires appreciating the hormone's essential functions in male physiology. Far from being merely a "female hormone," estrogen—specifically estradiol—plays vital roles in men's health that cannot be replicated by testosterone alone.
Bone Health and Skeletal Integrity
Estradiol is the dominant regulator of bone metabolism in men. Research consistently demonstrates that estrogen levels correlate more strongly with bone mineral density (BMD) than testosterone levels in elderly men. Estrogen regulates both bone formation (through osteoblast activity) and bone resorption (by suppressing osteoclast function).Men with genetic aromatase deficiency or estrogen receptor mutations develop severe osteopenia and unfused epiphyses despite having high testosterone levels. Clinical studies show that when anastrozole is used to suppress estrogen in older men, spine bone mineral density decreases significantly—by approximately 2-4% over one year. This loss of BMD translates directly to increased fracture risk, particularly in the spine and hips.
The concern is particularly acute for men taking anastrozole long-term. Data from breast cancer trials in women show significantly higher fracture rates with aromatase inhibitors compared to other treatments—an 11% fracture incidence with anastrozole versus lower rates with tamoxifen in the landmark ATAC trial. While direct long-term fracture data in men is limited, the bone loss mechanisms are similar across sexes.
Sexual Function and Libido
Contrary to popular belief, estradiol is essential for normal male sexual function. A landmark 2013 study by Finkelstein and colleagues demonstrated this clearly: when healthy men were given GnRH analogs to suppress their natural testosterone production, then given testosterone replacement with or without anastrozole, those receiving anastrozole showed significantly impaired libido and erectile function compared to men receiving testosterone alone.The relationship between estradiol and sexual function appears to follow a U-shaped curve—both too little and too much can cause problems. Studies suggest that libido is optimized when estradiol levels are above 5 pg/mL but not excessively elevated. Men with crashed estrogen from overuse of aromatase inhibitors commonly report erectile dysfunction, decreased sexual desire, reduced ejaculate volume, and difficulty achieving orgasm—symptoms that persist until estrogen levels recover.
Estradiol influences sexual function through multiple mechanisms: it affects nitric oxide production and blood vessel function crucial for erections, supports neurotransmitter activity involved in sexual desire, and helps maintain the health of reproductive tissues. These effects cannot be replicated by testosterone alone, as evidenced by men with complete aromatase deficiency who experience sexual dysfunction despite high testosterone levels.
Cardiovascular Health
Estrogen provides important cardiovascular protection in men through effects on blood vessel function, lipid metabolism, and inflammatory responses. Men with very low estradiol levels show impaired endothelial function and less favorable cardiovascular risk profiles.Studies in women taking aromatase inhibitors have demonstrated concerning cardiovascular signals. The ATAC trial found higher rates of ischemic cardiovascular events with anastrozole compared to tamoxifen in women with pre-existing heart disease. Systematic reviews have associated aromatase inhibitor therapy with increased heart failure and cardiovascular mortality. While direct evidence in men is more limited, several observational studies suggest correlations between low estradiol and increased cardiovascular risk.
The medication's effect on cholesterol levels adds another layer of concern. Anastrozole can increase total cholesterol and alter lipid profiles unfavorably. The FDA label for anastrozole specifically notes these effects and advises considering cholesterol monitoring—a practical reason to avoid casual use as part of routine TRT.
Metabolic Function and Body Composition
Estradiol plays a crucial role in metabolic regulation in men. Research shows that estradiol deficiency—even short-term—contributes to fat mass accumulation, with estradiol being a stronger determinant of adiposity than testosterone in some studies. The hormone influences insulin sensitivity, glucose metabolism, and lipid breakdown (lipolysis).A controlled study in healthy men found that pharmacologic aromatase inhibition reduced insulin-stimulated glucose disposal, effectively impairing insulin sensitivity. This metabolic impairment increases risk for metabolic syndrome, type 2 diabetes, and cardiovascular disease. Paradoxically, men taking anastrozole hoping to improve body composition may experience the opposite effect as estrogen suppression disrupts metabolic balance.
Estrogen also influences brain function, supporting mood regulation, cognitive performance, and memory formation. Men with very low estrogen may experience depression, anxiety, or cognitive difficulties that don't respond to traditional treatments until hormone levels are normalized.
When Might Anastrozole Be Appropriate?
Despite the concerns about routine use, there are specific clinical situations where anastrozole may be warranted for men on testosterone therapy. The key is identifying genuine estrogen excess rather than responding to laboratory values in isolation.Clinical Indications
Symptomatic gynecomastia (breast tissue enlargement and tenderness) represents the most clearly established indication for anastrozole in men on TRT. When gynecomastia develops or worsens during testosterone therapy and correlates with elevated estradiol levels, aromatase inhibition may help prevent progression. However, it's important to note that anastrozole is much less effective than tamoxifen for treating established gynecomastia, and once breast tissue has been present for more than a year, medical treatment is usually ineffective.Severe fluid retention (edema) that develops or worsens with TRT and doesn't respond to dose adjustment may warrant aromatase inhibitor use, particularly when associated with elevated estradiol. However, fluid retention has many causes, and estrogen excess should be confirmed rather than assumed. Water retention on TRT is usually caused by sodium retention by the kidneys caused by testosterone (the body tends to hold on to water to "dilute" the extra sodium.)
Very high estradiol levels with symptoms may justify intervention. A frequently cited protocol from Memorial Sloan Kettering Cancer Center used anastrozole for men with either estradiol levels above 60 pg/mL regardless of symptoms, or levels between 40-60 pg/mL with subjective symptoms like nipple tenderness. However, it's crucial to understand that these thresholds are not evidence-based guidelines but rather one institution's pragmatic approach.
Fertility Preservation
Anastrozole has a role in treating some forms of male infertility, particularly in men with elevated estradiol-to-testosterone ratios. By blocking estrogen's negative feedback on the hypothalamic-pituitary axis, the medication can increase endogenous LH and FSH production, potentially improving sperm production. This application is distinct from its use in men already on TRT—exogenous testosterone itself suppresses spermatogenesis regardless of estrogen levels.When NOT to Use Anastrozole
Routine prophylaxis with every TRT prescription is not supported by evidence and unnecessarily exposes men to potential harm. Most men on standard TRT doses do not develop problematic estrogen elevations.Elevated estradiol numbers without symptoms rarely warrant treatment. Estradiol levels considered "high" by some clinics (40-50 pg/mL) are often still within or near physiologic range and provide important health benefits.
As a substitute for testosterone in hypogonadal men is inappropriate. While anastrozole can modestly increase testosterone in some men, it does so by depleting estrogen—trading one hormone deficiency for another. Evidence-based treatment for hypogonadism is testosterone replacement, not estrogen suppression.
For body composition goals, anastrozole is counterproductive. Despite marketing claims, estrogen suppression impairs metabolic function and makes fat loss more difficult, not easier.
Dosing Protocols and Administration
When anastrozole is deemed clinically necessary, the principle should be to use the minimum effective dose to address specific symptoms while maintaining estradiol in a healthy range. Overly aggressive dosing is a common mistake that leads to the complications of estrogen deficiency.Standard Dosing Approaches
The most common starting dose is 0.5 mg taken 2-3 times per week. Some practitioners use even lower doses of 0.25 mg, particularly for men who are sensitive to hormonal changes. Men performing testosterone injections twice weekly often take anastrozole on the day of or day after injection, when testosterone peaks make aromatization most likely.Published protocols from clinical studies have used 0.5 mg three times weekly (for example, in the Memorial Sloan Kettering study) or 1 mg every other day for fertility applications. Daily dosing of 1 mg—the standard dose in breast cancer treatment—is rarely appropriate for men and carries higher risk of over-suppression.
For subcutaneous testosterone pellet therapy, some practitioners co-administer anastrozole pellets. Studies have used approximately 16 mg of anastrozole released over a 4-5 month period, equivalent to roughly 0.1 mg daily—a much lower continuous dose than intermittent oral administration.
Monitoring and Dose Adjustment
Baseline laboratory testing before starting anastrozole should include total testosterone, estradiol (using sensitive assay), and ideally sex hormone binding globulin (SHBG) to calculate free testosterone. Some practitioners also check hematocrit and PSA as part of comprehensive TRT monitoring.Follow-up testing should occur approximately 4-6 weeks after starting anastrozole or changing the dose, as steady-state hormone levels take time to establish. The goals are to ensure adequate estradiol reduction without over-suppression, verify that testosterone levels remain appropriate, and assess symptom resolution.
Many experienced practitioners aim for a testosterone-to-estradiol ratio between 10:1 and 20:1, though this is a pragmatic guideline rather than an evidence-based target. More importantly, estradiol should generally not fall below 10-20 pg/mL, as levels below this range significantly increase risks of bone loss, sexual dysfunction, and metabolic problems.
Ongoing monitoring every 3-4 months is appropriate once hormone levels stabilize. Any dose change in testosterone or anastrozole warrants repeat testing 4-6 weeks later. Long-term use should include periodic assessment of bone density (DEXA scan), lipid profiles, and cardiovascular risk markers given the potential adverse effects of chronic estrogen suppression.
Clinical Comparison: Anastrozole Dosing Protocols
Dosing Protocol | Typical Application | Considerations |
| 0.25 mg 2x per week | Conservative starting dose for sensitive individuals | Lowest risk of over-suppression; may require compounding pharmacy |
0.5 mg 2x per week | Most common starting dose; standard protocol for TRT | Balances efficacy with safety; used in published clinical studies. Risk of decreasing E2 excessively in some men. |
1 mg every other day | Male fertility protocols; very high estradiol | Higher dose; requires close monitoring; not for routine use. Not generally recommended. |
1 mg daily | Breast cancer treatment (postmenopausal women) | Rarely appropriate for men; high risk of over-suppression. AVOID in men on TRT. |
Side Effects and Safety Concerns
The side effects of anastrozole in men largely reflect the consequences of estrogen deficiency. Understanding these risks is essential for informed decision-making about whether to use the medication.Common and Serious Adverse Effects
Side Effect Category | Symptoms and Clinical Significance |
| Sexual Dysfunction | Decreased libido, erectile dysfunction, reduced ejaculate volume, difficulty achieving orgasm. These symptoms often persist until estradiol levels recover. |
Joint and Musculoskeletal | Joint pain, stiffness, and increased injury risk. Common complaints that may be severe enough to require discontinuation. |
Bone Loss | Progressive decrease in bone mineral density, particularly in spine. Long-term use significantly increases fracture risk, especially in older men. |
Neuropsychiatric | Depression, anxiety, mood swings, cognitive difficulties, fatigue. Men may feel similar to postmenopausal women experiencing estrogen deficiency. |
Metabolic | Impaired insulin sensitivity, increased fat accumulation (particularly visceral fat), unfavorable changes in cholesterol profile. |
Cardiovascular | Potential increased risk of ischemic events and heart failure based on data from women. Direct evidence in men is limited but concerning. |
Vasomotor | Hot flashes, night sweats—symptoms typically associated with estrogen deficiency in women but can occur in men with severely suppressed estradiol. |
Gastrointestinal | Nausea, diarrhea, upset stomach. Usually mild and may improve with continued use or dose reduction. |
Alternatives to Anastrozole
Before resorting to aromatase inhibitors, several alternative approaches deserve consideration for managing estrogen-related concerns during testosterone therapy.TRT Protocol Optimization
Dose reduction represents the simplest approach when estradiol rises disproportionately. Many men receive more testosterone than necessary, and reducing the dose often brings both testosterone and estradiol into more favorable ranges while maintaining clinical benefits.Injection frequency optimization can reduce peak testosterone levels that drive excessive aromatization. More frequent, smaller injections (such as every other day or daily) create more stable levels with lower peaks, potentially reducing estradiol spikes while maintaining consistent testosterone effects.
Route of administration changes may help some men. Transdermal testosterone (gels, creams) produces different patterns of aromatization compared to injections. Subcutaneous injection routes may behave differently than intramuscular. However, switching modalities should be done carefully with appropriate monitoring.
Lifestyle Modifications
Weight loss and body composition improvement directly address a primary driver of excessive aromatization. Adipose tissue is a major site of aromatase activity, so reducing body fat can significantly decrease estrogen production. This approach provides numerous other health benefits beyond hormone management.Alcohol reduction decreases aromatase activity and improves liver function, both of which can help normalize estrogen levels. Chronic alcohol consumption increases estrogen and reduces testosterone through multiple mechanisms.
Alternative Medications
Tamoxifen (Nolvadex) is a selective estrogen receptor modulator (SERM) that blocks estrogen receptors in breast tissue while maintaining estrogenic activity in bone and some other tissues. For gynecomastia prevention or treatment, tamoxifen is more effective than anastrozole and preserves the beneficial effects of estrogen on bone and lipids. However, it doesn't lower estradiol levels and may affect vision in some men.Other aromatase inhibitors like letrozole (Femara) or exemestane (Aromasin) work similarly to anastrozole. They don't offer significant advantages for most men and carry similar risks of estrogen deficiency. Letrozole is actually more potent and may increase risk of over-suppression.
Expert Perspectives and Controversy
The use of anastrozole in men on TRT remains one of the most debated topics in men's health, with passionate advocates on both sides of the argument.The Case Against Routine Use
Many hormone specialists, including Dr. Neal Rouzier and others, argue strongly against routine anastrozole use. Their position rests on several key points:• No evidence that "elevated" estradiol (in the 40-60 pg/mL range) causes harm in men with adequate testosterone
• Substantial evidence that low estradiol causes multiple health problems
• Many supposed symptoms of "high estrogen" (fatigue, low libido, weight gain) occur with both high AND low estrogen
• Testosterone's benefits depend partly on its conversion to estrogen
• Long-term safety concerns about bone loss and cardiovascular risk
This perspective emphasizes that estrogen is not the enemy—it's an essential hormone that men need for optimal health.
The Case for Selective Use
Other practitioners, particularly those managing men with very high testosterone doses or specific symptoms, maintain that anastrozole has a legitimate role:• Some men genuinely develop gynecomastia or severe edema on TRT
• Estradiol levels above 70-80 pg/mL may cause problems in some individuals
• Individual variation means some men respond poorly to elevated estrogen
• When used carefully with monitoring, anastrozole can be safe and effective
This more nuanced view acknowledges concerns about routine use while maintaining that the medication has legitimate applications in specific clinical scenarios.
Practical Protocol Recommendations
Based on current evidence and clinical experience, here is a framework for approaching anastrozole use in men on testosterone therapy:Initial TRT Management
• Start TRT without anastrozole in most men• Use conservative testosterone doses initially (75-125 mg per week for most men)
• Monitor testosterone AND estradiol at 6-8 weeks
• Assess for actual symptoms (breast tenderness, severe fluid retention) rather than laboratory values alone
• Optimize TRT protocol (dose, frequency) before adding additional medications
When to Consider Anastrozole
• Development of gynecomastia with confirmed elevated estradiol• Severe, persistent edema despite dose adjustment. However, there are no studies on the effect of anastrozole on water retention in men.
• Estradiol above 70 pg/mL with clear symptoms
• Failed attempts to manage through TRT protocol optimization
Implementation Guidelines
• Start with lowest effective dose (0.25-0.5 mg 2x per week)• Recheck labs after 4-6 weeks
• Target sensitive estradiol above 20 pg/mL minimum (preferably 25-35 pg/mL). Make sure that the lab test is based on gas chromatography/mass spectrometry.
• Monitor for symptoms of low estrogen (joint pain, sexual dysfunction, mood changes)
• Consider periodic breaks or dose reduction to assess ongoing need
• Obtain baseline DEXA scan if planning long-term use
Special Considerations for TRT Patients
Aromatization Variability
Individual differences in aromatase enzyme activity mean that men respond very differently to the same testosterone dose. Factors influencing aromatization include:• Body composition: Higher body fat, especially visceral adiposity, dramatically increases aromatase activity
• Genetic variations: Polymorphisms in the CYP19A1 gene (which codes for aromatase) create high and low aromatizers
• Age: Aromatase activity generally increases with aging, though testosterone production decreases
• Insulin resistance: Metabolic syndrome and diabetes increase aromatase expression
• Liver function: The liver metabolizes estrogen; impaired function leads to accumulation
The "Crashed" Estradiol Problem
One of the most common complications seen in men taking anastrozole and posting on the ExcelMale forum—particularly those using it without proper monitoring—is excessively suppressed estradiol. This "crashed E2" syndrome can be remarkably unpleasant and potentially dangerous:Men with estradiol below 10 pg/mL often experience severe symptoms: profound fatigue, complete loss of libido, erectile dysfunction, irritability and emotional volatility, anxiety and depression, painful joints throughout the body, and dry, cracking skin. Some describe feeling like they've aged 20 years overnight. The cognitive effects can be particularly distressing—brain fog, poor concentration, and memory problems.
Recovery from crashed estradiol requires stopping anastrozole and waiting for levels to normalize, which can take 2-4 weeks given the drug's long half-life. Some practitioners use low-dose topical estrogen to accelerate recovery, though this approach is also off-label and somewhat controversial.
Long-Term Safety Monitoring
Men using anastrozole chronically should have comprehensive monitoring beyond just hormone levels:• Bone density (DEXA scan): Baseline before starting, repeat every 1-2 years during treatment
• Lipid panel: Monitor for adverse changes in cholesterol
• Metabolic markers: Fasting glucose, HbA1c, insulin sensitivity indices
• Cardiovascular assessment: Blood pressure, cardiovascular risk scores
• Clinical symptoms: Regular review of sexual function, mood, energy, and physical performance
Key Takeaways
• Anastrozole is a potent aromatase inhibitor that reduces estrogen production by blocking the conversion of testosterone to estradiol• Estrogen is essential for male health—not a hormone to be minimized. It's critical for bone density, sexual function, cardiovascular health, cognitive function, and metabolic regulation
• Routine prophylactic use of anastrozole with TRT is not supported by evidence and exposes men to unnecessary risks
• Specific clinical indications include symptomatic gynecomastia, severe fluid retention, or very high estradiol with clear symptoms
• When used, anastrozole should be dosed conservatively (typically 0.25-0.5 mg 2-3x per week) with careful monitoring to avoid over-suppression
• Side effects of excessive estrogen suppression include sexual dysfunction, bone loss, metabolic problems, joint pain, and mood disturbances
• Before adding anastrozole, optimize TRT protocol through dose adjustment, frequency changes, and lifestyle modifications
• Long-term use requires monitoring of bone density, lipids, metabolic markers, and cardiovascular health
• Target estradiol levels should generally remain above 20 pg/mL, ideally 25-35 pg/mL, to maintain beneficial effects
• Work with a knowledgeable physician who understands the risks and benefits of anastrozole rather than using it casually or based on online recommendations
Conclusion
The decision to use anastrozole during testosterone replacement therapy should never be automatic. While this medication has legitimate applications in specific clinical scenarios, mounting evidence suggests that routine co-administration causes more problems than it solves. Estrogen is not the enemy—it's a vital hormone that men need for optimal health, sexual function, bone strength, and metabolic balance.For most men on well-managed TRT, estradiol levels will rise proportionally with testosterone but remain within a range that provides benefits without causing problems. The minority of men who develop true estrogen-related symptoms may benefit from anastrozole, but only when used judiciously, at appropriate doses, with careful monitoring, and with full awareness of potential long-term risks.
The take-home message is simple: respect estrogen's essential role in male physiology, question any protocol that routinely suppresses it, and if anastrozole is necessary, use the minimum effective dose for the shortest time required. Your bones, heart, brain, and sexual function will thank you.
Download Anastrozole for Men Slides Here
Related ExcelMale Forum Discussions
Explore these community discussions for additional insights and real-world experiences:• Complete Guide to Anastrozole for Men – Comprehensive overview of anastrozole use, dosing, and considerations
• Aromatase Inhibitors Decrease Male Sexual Desire – Discussion of research showing negative effects on libido
• Anastrozole Enduring Side Effects 5 Years Later – Personal account of long-term complications from anastrozole use
• Anastrozole Dosing and Timing – Community discussion on optimal dosing protocols
• Any Concerns About Long-Term Anastrozole Use in Men? – Discussion of safety concerns with prolonged use
• Estradiol is an Important Hormone for Men – Foundational discussion on estrogen's role in male health
• High Estradiol in Men: How High is Too High? – Community debate on estradiol target ranges
• Role of Estradiol/Estrogen in Men and Its Management – Long-standing thread on estrogen management strategies
• Crashed Estradiol Discussions – Multiple threads discussing recovery from over-suppressed estrogen
• Estradiol Topics on ExcelMale – Browse all forum discussions tagged with estradiol
Key References
1. Punjani N, Bernie H, Salter C, et al. The Utilization and Impact of Aromatase Inhibitor Therapy in Men With Elevated Estradiol Levels on Testosterone Therapy. Sex Med. 2021;9(4):100378. [PubMed]2. de Ronde W, de Jong FH. Aromatase inhibitors in men: effects and therapeutic options. Reprod Biol Endocrinol. 2011;9:93. [PubMed Central]
3. Finkelstein JS, Lee H, Burnett-Bowie SA, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013;369(11):1011-1022. [Journal]
4. Khosla S, Monroe DG. Regulation of bone metabolism by sex steroids. Cold Spring Harb Perspect Med. 2018;8(1):a031211. [PubMed Central]
5. Leder BZ, LeBlanc KM, Schoenfeld DA, et al. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab. 2003;88(1):204-210. [PubMed]
6. T'Sjoen G, Kaufman JM, Goemaere S, et al. The effects of the aromatase inhibitor anastrozole on bone metabolism and cardiovascular risk indices in ovariectomized, androgen-treated female-to-male transsexuals. Eur J Endocrinol. 2006;154(4):569-575. [Journal]
7. Glaser R, York AE. Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy. Int J Pharm Compd. 2019;23(4):324-332. [PubMed]
8. Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol. 2013;189(1 Suppl):S34-S42. [PubMed Central]
9. Ramasamy R, Armstrong JM, Lipshultz LI. Preserving fertility during testosterone replacement therapy: current strategies and future directions. Asian J Androl. 2015;17(2):197-200. [PubMed Central]
10. Hadji P. Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis. Crit Rev Oncol Hematol. 2009;69(1):73-82. [PubMed]
11. Dhindsa S, Ghanim H, Batra M, Dandona P. Hypogonadotropic Hypogonadism in Men With Diabesity. Diabetes Care. 2018;41(7):1516-1525. [PubMed]
12. Vanderschueren D, Laurent MR, Claessens F, et al. Sex steroid actions in male bone. Endocr Rev. 2014;35(6):906-960. [PubMed Central]
Medical Disclaimer
This article is provided for informational and educational purposes only and is not intended as medical advice. Anastrozole is a prescription medication that should only be used under the supervision of a qualified healthcare provider. The information presented here should not be used to diagnose or treat any medical condition, nor should it replace professional medical consultation.Every individual's hormone response is unique, and what works for one person may not be appropriate for another. Before starting, stopping, or changing any medication—including anastrozole—consult with your physician. Laboratory testing and medical monitoring are essential when using hormone therapy.
ExcelMale.com and the author do not assume any liability for the use or misuse of the information contained in this article. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
About ExcelMale
ExcelMale.com is the leading online community for men's health, testosterone replacement therapy, and hormone optimization. Founded over 20 years ago, our forum brings together 24,000+ members who share experiences, research, and support for navigating TRT and related health concerns.Unlike commercial TRT clinics, ExcelMale provides unbiased, evidence-based information drawn from peer-reviewed research, clinical experience, and the collective wisdom of thousands of men who have optimized their health through informed decision-making. Our extensive archives contain detailed discussions on every aspect of men's hormone health, from basic TRT protocols to advanced optimization strategies.
Nelson Vergel, founder of ExcelMale, is a chemical engineer, patient advocate, and author of two acclaimed books: Built to Survive, Testosterone: A Man's Guide and Beyond Testosterone. With decades of personal experience and extensive research, Nelson has helped thousands of men navigate the complexities of hormone optimization safely and effectively.
Join the conversation at ExcelMale.com to connect with knowledgeable community members and access our extensive library of resources on TRT and men's health.
Last edited:
